Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
VinaCapital Vietnam Opportunity Fund Ltd | 1VV | Nov 21, 2024 | 5.05 | +0.40 |
Vince Holding Corp | VNC1 | Nov 21, 2024 | 1.30 | 0.00 |
Vinci | SQUA | Nov 21, 2024 | 24.80 | 0.00 |
Vinci SA | SQU | Nov 21, 2024 | 100.55 | -0.10 |
VinFast Auto | 0TL | Nov 21, 2024 | 3.69 | -0.97 |
VINPAI S.A. EO -,10 | J7Y | Nov 21, 2024 | 2.98 | -1.32 |
Viohalco SA/NV | VHC | Nov 21, 2024 | 4.93 | +1.44 |
Vior Inc | VL5 | Nov 21, 2024 | 0.10 | -13.45 |
Viper Energy Inc | ZT0 | Nov 21, 2024 | 51.00 | +2.82 |
Vipshop Holdings Limited American Depositary Shares, each re | 1VPA | Nov 21, 2024 | 12.70 | +3.25 |
Viracta Therapeutics, Inc. | RYI | Nov 21, 2024 | 0.12 | -0.83 |
Virbac SA | V16 | Nov 21, 2024 | 312.50 | -1.57 |
VIREO GROWTH INC. | 0ZF | Nov 21, 2024 | 0.33 | +3.82 |
Virgin Galactic | 0QL0 | Nov 21, 2024 | 6.31 | -0.24 |
Virgin Galactic Holdings Inc | 0QL | Nov 21, 2024 | 0.64 | 0.00 |
Virginia National Bankshares Corp | 71F | Nov 21, 2024 | 39.00 | -2.01 |
Viridian Therapeutics, Inc. | 1S1 | Nov 21, 2024 | 18.40 | -1.60 |
Viridien | GDG0 | Nov 21, 2024 | 39.20 | 0.00 |
VIROMED MEDICAL INH O.N. | VMED | Nov 21, 2024 | 2.10 | 0.00 |
VirTra, Inc. | 0XQ | Nov 21, 2024 | 7.00 | +1.45 |
Virtu Financial, Inc. - Class A | 0VF | Nov 21, 2024 | 35.80 | +2.29 |
Virtus AllianzGI Artificial Intelligence & Technology Opport | 3X80 | Nov 21, 2024 | 21.65 | +0.91 |
Virtus Investment Partners, Inc. | VIP | Nov 21, 2024 | 222.00 | +0.91 |
Visa Inc | 3V6 | Nov 21, 2024 | 19.80 | +1.02 |
Visa Inc. | 3V64 | Nov 21, 2024 | 295.45 | +1.77 |
Viscofan S.A. | VIS | Nov 21, 2024 | 63.10 | +1.77 |
Viscom SE | V6C | Nov 21, 2024 | 3.09 | -0.64 |
Vishay Intertechnology, Inc. | VHY | Nov 21, 2024 | 14.62 | +0.59 |
Visible Gold Mines Inc | 3V41 | Nov 21, 2024 | 0.04 | +1.23 |
Visiomed Group | 7V91 | Nov 21, 2024 | 0.16 | -2.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.